PIRFENIDONE ACCORD 267 mg, film-coated tablet 252 tablets
Active ingredients: PIRFÉNIDONE
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet252 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- PIRFENIDONE ACCORD 267 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquettes prédécoupées unitaires PVC polyéthylène polychlortrifluoroéthylène aluminium de 252 x 1 comprimé. Conditionnement multiple (pour traitement d'entretien) de 3 boîtes de 84 comprimés (12 plaquettes de 7 comprimés)
- Marketing authorisation holder
- ACCORD HEALTHCARE FRANCE
- Reimbursement according to BDPM
- 30 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 24 Jun 2024
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by a hospital doctor
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64950346CIP73027473CIP133400930274736Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| PIRFÉNIDONEcomprimé | 267 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
Group of similar medicines: PIRFENIDONE 267 mg - ESBRIET 267 mg, comprimé pelliculé